---
title: GxP Standards Glossary
sidebar_label: Glossary
---

# GxP Standards Glossary

A quick-reference dictionary aligned with FDA (21 CFR) and EU GMP (EudraLex Vol. 4) terminology. Use these definitions consistently across SOPs and records.

## Data Integrity & Documentation
| Term | Definition | Regulatory anchor |
| --- | --- | --- |
| **ALCOA+** | Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available. Foundation of GDP/data integrity. | FDA 21 CFR 211.68/211.188; EU GMP Ch.1 & Ch.4; PIC/S PI 041 |
| **Good Documentation Practice (GDP)** | Rules ensuring records are legible, permanent, contemporaneous, accurate, traceable, and properly corrected. | EU GMP Ch.4; FDA 21 CFR 211.180/188 |
| **True Copy** | Verified copy that preserves content/meaning of the original (incl. metadata if electronic). | EU GMP Annex 11 §9; WHO TRS 1033 |
| **Audit Trail (paper)** | Visible, legible record of changes (single-line strike-through, initials/date/reason). | EU GMP Ch.4.9; FDA data integrity guidance |
| **Master Batch Record (MBR)** | Approved template for a product/batch; controlled and versioned. | FDA 21 CFR 211.186 |
| **Batch Production Record (BPR)** | Executed record generated from the MBR for a specific batch. | FDA 21 CFR 211.188 |
| **Qualified Person (QP)** | EU role that certifies each batch before release to market. | EU GMP Ch.1.4; Directive 2001/83/EC |
| **QP Certification / Batch Release** | Formal release step recorded and signed/dated by QP. | EU GMP Ch.1.6 |

## GMP, Qualification & Validation
| Term | Definition | Regulatory anchor |
| --- | --- | --- |
| **GMP** | Good Manufacturing Practice; covers facilities, equipment, personnel, documentation, production, QC. | FDA 21 CFR 210–211; EU GMP |
| **Qualification** | IQ/OQ/PQ: demonstrate equipment/utility is installed, operates, and performs as intended. | EU GMP Annex 15; FDA 211.63/68 |
| **IQ / OQ / PQ** | Installation, Operational, Performance Qualification. | EU GMP Annex 15 §3; FDA 211.63/68 |
| **Calibration** | Demonstrating instrument accuracy vs. traceable standard at defined intervals. | FDA 211.160(b); EU GMP Annex 15 |
| **Process Validation** | Evidence that a process consistently produces product meeting specs (often Stage 1–3 lifecycle). | FDA PV Guidance 2011; EU GMP Annex 15 |
| **Change Control** | Formal assessment/approval of changes to facilities, equipment, documents, or processes. | EU GMP Ch.1.4(xiv); FDA 211.100(a) |
| **CAPA** | Corrective and Preventive Action to remove root causes of deviations/complaints. | FDA 211.192/198; EU GMP Ch.1 |
| **Deviation / Nonconformance** | Unplanned departure from approved instruction/spec; requires documented investigation. | FDA 211.100/211.192; EU GMP Ch.1 |

## Distribution & GDP (Good Distribution Practice)
| Term | Definition | Regulatory anchor |
| --- | --- | --- |
| **GDP (Distribution)** | Controls to ensure product quality during storage/transport (temperature, security, traceability). | EU GDP 2013/C 343/01; WHO GDP TRS 957 |
| **Cold Chain / Controlled Room Temp (CRT)** | Qualified storage/transport ranges (e.g., 2–8 °C; 15–25 °C) with continuous monitoring and alarms. | EU GDP §3.2; WHO GDP |
| **Temperature Excursion** | Time outside qualified range; must be assessed, documented, and approved before release. | EU GDP §9; FDA 211.150(b) |
| **FEFO** | First-Expired-First-Out stock rotation. | EU GDP §5 |

## Laboratory & Quality Control
| Term | Definition | Regulatory anchor |
| --- | --- | --- |
| **Analytical Method Validation** | Demonstration of accuracy, precision, specificity, etc., for intended use. | ICH Q2(R2); FDA 211.165(e) |
| **Out of Specification (OOS)** | Test result outside specification; requires phase 1/2 investigation and documented conclusion. | FDA OOS Guidance; EU GMP Ch.6 |
| **Out of Trend (OOT)** | Result within spec but atypical versus historical data; triggers assessment. | EU GMP Ch.6; EMA OOT Q&A |

## Roles & Records
| Term | Definition | Regulatory anchor |
| --- | --- | --- |
| **Authorized Signatory / Signature Log** | Controlled record linking initials/signatures to individuals for attribution. | EU GMP Ch.4.8; FDA 211.186/194 |
| **Line Clearance** | Documented check that area/equipment is clean and free of previous materials before use. | FDA 211.130(e); EU GMP Annex 15 §8 |
| **Label Reconciliation** | Accounting for issued/used/returned/voided labels; discrepancies investigated. | FDA 211.125(c); EU GMP Annex 15 §8.13 |

## Computerized System Context (Paper scope references)
| Term | Definition | Regulatory anchor |
| --- | --- | --- |
| **Part 11 (ERES)** | US requirements for electronic records/signatures (applicable when systems are electronic). | FDA 21 CFR Part 11 |
| **Annex 11** | EU expectations for computerized systems (audit trails, validation, security). | EU GMP Annex 11 |
| **True Copy / Printout Control** | When electronic data are printed and attached to paper records, ensure authenticity and linkage. | Annex 11 §9; FDA DI guidance |

## Change, Risk, and QA Systems
| Term | Definition | Regulatory anchor |
| --- | --- | --- |
| **Risk Assessment** | Formal evaluation of impact/severity/probability to justify control strategy. | ICH Q9(R1); EU GMP Ch.1.5 |
| **Periodic Review** | Scheduled review of systems/equipment/data to confirm they remain in a state of control. | Annex 11 §1; EU GMP Ch.1 |
| **Recall / Market Withdrawal** | Removal of product from market; documented decision, lot traceability, and effectiveness checks. | FDA 21 CFR 7; EU GMP Ch.8 |

---

*Regulatory anchors reference FDA 21 CFR Parts 210–211/11, EU GMP (EudraLex Vol.4) Chapters 1,4,6,8, Annex 11, Annex 15, EU GDP 2013/C 343/01, WHO GDP and PIC/S PI 041.* 
